NATCO Pharma Limited (NSE:NATCOPHARM)

NATCO Pharma Revenue

NATCO Pharma had revenue of 7.35B INR in the quarter ending June 30, 2026, a decrease of -44.68%. This brings the company's revenue in the last twelve months to 34.85B, down -20.73% year-over-year. In the fiscal year ending March 31, 2026, NATCO Pharma had annual revenue of 40.82B, down -7.90%.

• Revenue (ttm): 34.85B
• Revenue Growth: -20.73%
• P/S Ratio: 4.19
• Revenue / Employee: 7.86M
• Employees: 4,199
• Market Cap: 146.04B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	40.82B	-3.50B	-7.90%
Mar 31, 2025	44.32B	4.30B	10.74%
Mar 31, 2024	40.02B	12.94B	47.76%
Mar 31, 2023	27.09B	7.62B	39.17%
Mar 31, 2022	19.46B	-1.10B	-5.35%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 11, 2026

Data Sources Report a data error